What is Arvinas's EBITDA?

Arvinas (ARVN) reported EBITDA of -$63.1M in Q1 2026.

How has Arvinas's EBITDA changed year-over-year?

Arvinas's EBITDA decreased by 187.5% year-over-year, from $72.1M to -$63.1M.

What is the long-term trend for Arvinas's EBITDA?

Over 4 years (2021 to 2025), Arvinas's EBITDA has grown at a -10.9% compound annual growth rate (CAGR), from -$183.6M to -$115.5M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Arvinas ARVN EBITDA

EBITDA at other companies

Nurix Therapeutics, Inc.NRIX

-$90.3M-49.2%

Kymera TherapeuticsKYMR

-$82.13M-13.5%

Monte Rosa Therapeutics, Inc.GLUE

-$48.01M-204%

Relmada Therapeutics, Inc.RLMD

-$26.46M-148%

ArriVent BioPharma, Inc.AVBP

-$46.67M+30.9%

ImmunomeIMNM

-$58.73M-33.4%

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Calculated from Arvinas’s reported figures.

−$63.8Mebit+

$700.0KDepreciation Depletion & Amortization

=-$63.1M

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's EBITDA?: Arvinas (ARVN) reported EBITDA of -$63.1M in Q1 2026.
How has Arvinas's EBITDA changed year-over-year?: Arvinas's EBITDA decreased by 187.5% year-over-year, from $72.1M to -$63.1M.
What is the long-term trend for Arvinas's EBITDA?: Over 4 years (2021 to 2025), Arvinas's EBITDA has grown at a -10.9% compound annual growth rate (CAGR), from -$183.6M to -$115.5M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.